In a first-person column, Dr. Foluso Fakorede argues that America is experiencing what he calls a preventable “Black American amputation epidemic,” driven largely by undiagnosed peripheral artery disease and unequal access to care.
The piece draws on his decade treating patients in the Mississippi Delta.
Fakorede, the only cardiovascular specialist in Bolivar County, frames the crisis through both his patients and his own family. His grandmother died at 62 from diabetes complications, he writes, and both his parents live with diabetes and neuropathy. “For me, this fight is not simply professional; it is personal, generational, and profoundly human,” he writes in the column.
The stakes he lays out are stark. Black patients lose limbs at three to four times the rate of other racial groups, a disparity he attributes to ZIP codes rather than disease severity. He reports that timely screening and access to care in Mississippi cut major amputation rates by 87.5% over four and a half years. The problem, in other words, isn’t the medicine. It’s the delivery.
“If we can change the narrative of health care here in the Mississippi Delta, we can change the future of limb preservation everywhere,” Fakorede writes.

Screening and Access Cut Amputations by 87.5%
- Dr. Foluso Fakorede argues in a column that most amputations among Black Americans stem from undiagnosed peripheral artery disease, not inevitable disease progression.
- His Mississippi practice reduced major amputations by 87.5% in four and a half years through screening and access.
- He calls for community-level policy, more specialists in underserved areas, and routine circulation checks at standard medical visits.
A ‘Leg Attack’ Nobody Has Heard Of
Peripheral artery disease, or PAD, occurs when plaque narrows the arteries carrying oxygen-rich blood to the legs. Early on, patients may feel nothing; later, leg pain, non-healing wounds, ulcers, and gangrene follow. Fakorede notes that most readers have never heard of PAD, yet everyone knows the word “amputation.”
He offers a blunt rebrand: had PAD been called a “leg attack” from the start, he argues, it would command the same urgency as a heart attack. The American Heart Association’s PAD Amputation Heat Map, which he cites, shows the geographic and racial disparities in stark relief.
The scale is enormous. As many as 236 million people worldwide live with PAD, including an estimated 12 million U.S. adults over 40. Yet the disease remains, in his words, largely unknown, undetected, and undertreated.
When Your ZIP Code Decides the Outcome
But the math tells a different story about who bears the burden. Fakorede writes that the greatest predictor of whether some patients keep their limbs is not disease severity but where they live. Too many patients, he argues, never get screened, never see a vascular specialist, and reach amputation as their first and only option.
The detection tools are cheap and old. A physical exam with socks off, plus an ankle-brachial index test comparing blood pressure at the ankle with the arm, can flag impaired circulation before irreversible damage. According to measures are routinely skipped at checkups. The consequences of undiagnosed PAD can be as deadly as many cancers.
Even when PAD is caught, he argues, the system fails. Guideline-directed therapies are scientifically proven and largely inexpensive, he writes, and minimally invasive procedures to reopen blocked vessels exist. Yet too many patients undergo amputation without ever receiving a vascular evaluation — a failure he extends to nurses, medical students, and practicing doctors who misdiagnose the disease.
What the Column Asks For
Fakorede’s prescriptions are policy-level, not bedside. He calls for community-level strategies targeted at ZIP codes with high amputation rates, both rural and urban, alongside equalized access to providers and insurance coverage. Access, he writes, means little if patients cannot afford medications, reach appointments, or understand their care.
He also points to the shared cost. The financial burden of preventable amputations on the health system and taxpayers is staggering, alongside the devastation to the workforce and the loss of heads of households. Drawing parallels to HIV and addiction, he argues that whatever harms one person harms many others indirectly.
| Figure | Detail | Source cited in column |
|---|---|---|
| 236 million | People affected by PAD worldwide | column |
| 12 million | U.S. adults over 40 with PAD | column |
Why This Column Lands Now
The piece arrives as health-care-desert coverage has become a fixture of national conversation, and Fakorede positions the Delta as the test case. “When geography becomes destiny and amputation becomes a lottery,” he writes, “we must move beyond scientific knowledge and research to document the disparities needed to dismantle the barriers.” The evidence he offers — an 87.5% reduction achieved in one of America’s poorest regions — is the strongest card he plays.
He closes on the detail that sharpens everything: a disease most readers can’t name, and a procedure everyone can.